期刊文献+

动脉粥样硬化易损斑块干预治疗的研究进展 被引量:8

Research Progress in the Intervention of Atherosclerotic Vulnerable Plaques
下载PDF
导出
摘要 动脉粥样硬化(AS)的形成有一个渐进的过程,受到多重因素的影响,尤其是脂质紊乱。AS已经成为严重危害人类健康的疾病。但是,并不是所有的AS都可诱发心脑血管疾病,主要与斑块是否稳定有关。如果不给予有效的干预措施,就会导致临床心脑血管事件的发生。目前,虽然多种药物可稳定易损斑块,但缺少最佳的干预和治疗方法。因此,对斑块易损性的研究与干预已成为研究的热点。 The formation of atherosclerosis(AS)is a gradual process.It is subjected to multiple factors,especially lipid disorders.AS has become a serious diseases hazarded to human health.However,not all AS can induce cardiovascular and cerebrovascular disease,which is mainly related to the stability of the plaque.If effective interventions are not provided,it will lead to clinical cardiovascular and cerebrovascular events.Currently,a variety of drugs can stabilize vulnerable plaques,but optimal intervention and treatment is still not found.Therefore,research and intervention of plaque vulnerability has become a research hotspot.
出处 《医学综述》 2012年第21期3596-3598,共3页 Medical Recapitulate
基金 南京军区总医院博士后课题资助项目(53431002) 徐州市科委课题资助项目(XF11C103)
关键词 动脉粥样硬化 易损斑块 治疗 Atherosclerosis Vulnerable plaque Intervention
  • 相关文献

参考文献25

  • 1Mizuno Y, Jacob RF, Mason RP. Inflammation and the development of atherosclerosis [ J ]. J Atheroscler Thromb,2011,18 (5) :351-358.
  • 2张梅,陈良,张运.动脉粥样硬化易损斑块干预进展[J].中国医学前沿杂志(电子版),2011,3(5):12-15. 被引量:4
  • 3Valgimigli M, Agostoni P, Serruys PW. Acute coronary syndromes : an emphasis shift from treatment to prevention, and the enduring challenge of vulnerable plaque detection in the cardiac catheteriza- tion laboratory [ J ]. J Cardiovasc Med (Hagerstown) , 2007,8 ( 4 ) : 221-229.
  • 4Liang C, Xiaonan L, Xiaojun C, et al. Effect of metoprolol on vul- nerable plaque in rabbits by changing shear stress around plaque and reducing inflammation [ J ]. Eur J Pharmacol, 2009,613 ( 1/ 3) :79-85.
  • 5Shiomi M, Yamada S, ho T. Atherema stabilizing effects of simvas- tatin due to depression of macrephages or lipid accumulation in the atherematous plaques of coronary plaque-prone WHHL rabbits [ J ]. Atheresclerosis ,2005,178 ( 2 ) :287-294.
  • 6Matsumura T, Kinoshita H, Ishii N, et al. Telmisartan exerts antia- therosclerotie effects by activating peroxisome proliferator-activated receptor-Tin macrophages [ J ]. Arterioscler Thromb Vasc Biol,2011,31 (6) :1268-1275.
  • 7Schupp M, Janke J, Clasen R, et al. Angiotensin type 1 receptor blockers induce peroxisome prolfferator-activated receptor-,activity [ J ]. Circulation,2004,109 ( 17 ) :2054-2057.
  • 8Grothusen C, Bley S, Selle T, et al. Combined effects of HMG-CoA- reductase inhibition and renin-angiotensin system blockade on ex- perimental atherosclemsis [ J ]. Athemsclemsis, 2005, 182 ( 1 ) : 57-69.
  • 9Musunuru K, Blumenthal SR. The implications of the ezetimibe and simvastatin in hypercholesterolemia enhances atherosclerosis re- gression trial:a return to first principles[J]. Clin CardioI,2008,31 (6) :288-290.
  • 10Kastelein JJ, Sager PT, de Groot E, et al. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hyperoholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression ( ENHANCE ) trial [ J ]. Am Heart J 2005,149(2) :234-239.

二级参考文献51

  • 1郭远林,陈纪林.选择性环氧化酶-2抑制剂对载脂蛋白E基因敲除小鼠动脉粥样硬化影响的实验研究[J].中国循环杂志,2005,20(2):148-151. 被引量:2
  • 2吴静,吴钢.颈动脉内膜-中膜厚度与缺血性脑血管病[J].国际脑血管病杂志,2006,14(11):850-854. 被引量:17
  • 3CELERMAJER D S, SORENSEN K,RYALLS M,et al. Non-invasive detection of endonthelial dysfunction in children and adults at risk of atherosclerosis[J].Lancet, 1992,390:1111- 1115.
  • 4Libby P. Inflammation in atheroselerosis[J]. Nature,2002 ;420:868-74.
  • 5Hersh EV, Lally ET, Moore PA. Update on cyclooxygenase inhibitors : has a third COX isoform entered the fray [J]? Curr Med Res Opin,2005 ;21.
  • 6Stemme V, Swedenborg J, Claesson H, et al. Expression of cyclooxygenase-2 in human atherosclerotic carotid arteries[J]. Eur J Vasc Endovasc Sug,2000;20(2) :146-52.
  • 7Sehonbeek U, Sukhova GK, Greber P,et al. Augmented expression of eyclooxygenase-2 in human atherosclerotic lesions [J]. Am J Pathol, 1999; 155(4) :1281-91.
  • 8Me Geer PL,Mc Geer EG,Yasojima K. Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques [J]. Exp Gerontol,2002 ;37 (7) :925- 9.
  • 9Linton MF, Fasio S. Cyclooxygenase-2 and atherosclerosis [J]. Curr Opin Lipidol, 2002 ; 13 ( 5 ) :497-504.
  • 10Burleigh ME, Bahaev VR, Ooates JA, et al. Cyclooxygenase-2 promotes early atheroselerotic lesion formation in LDL receptor deficient mice [J]. Circulation ,2002 ; 105 ( 15 ) : 1816-23.

共引文献22

同被引文献151

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部